Sygnature Discovery hosts Kinase 2016: Next Generation Inhibitors

16th & 17th May 2016 – Nottingham, UK – Sygnature Discovery sponsored and hosted the Kinase 2016: Next Generation Inhibitors symposium at BioCity Nottingham this year.  This is the first time the conference has been held in Nottingham and it was a sell-out. Over 120 delegates attended the two-day symposium which included exceptional keynote speakers, […]

Caldan Therapeutics collaborates with Sygnature Discovery

17th May 2016 – Glasgow, UK – Caldan Therapeutics  announces that it has entered into integrated drug discovery collaboration with Sygnature Discovery Limited (Nottingham, UK). Sygnature will provide medicinal chemistry, computational sciences and informatics, bioscience and DMPK resource and intellectual input to complement Caldan’s existing capabilities and Type 2 Diabetes expertise. Click here to view Caldan’s […]

Sygnature achieves ‘The Sunday Times Heathrow SME Export Track 100’ for the 2nd year running

15th May 2016 – Nottingham, UK – We are delighted to announce that Sygnature Discovery has been placed No 65 in The Sunday Times Heathrow SME Export Track 100 published in the Business section of The Sunday Times on 15th May 2016. The listing reflects Sygnature’s continued advances in supporting the  global pharmaceutical industry with […]

Topping-out ceremony for Sygnature’s new Discovery Building

29th April 2016 – Nottingham, UK – A significant milestone was passed during  the construction of the new £30 million Discovery Building at BioCity Nottingham, which will become Sygnature Discovery’s new headquarters from March 2017. The topping-out ceremony took place on Friday 29th April 2016 with developers, contractors and Nottingham City Council (NCC) leaders coming […]

Page 5 of 11« First...34567...10...Last »
Copyright © 2017 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.